Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

384 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Panel Discussion - Problems in the Cancer Genomic Medicine].
Ishioka C, Muto M, Yachida S, Shirota H, Hirasawa A, Miyagawa K, Ashizawa K, Kinoshita I, Nishihara H, Matsuura N, Sakurai A. Ishioka C, et al. Among authors: hirasawa a. Gan To Kagaku Ryoho. 2022 Sep;49(9):1014-1017. Gan To Kagaku Ryoho. 2022. PMID: 36156030 Japanese.
Japan Society of Clinical Oncology provisional clinical opinion for the diagnosis and use of immunotherapy in patients with deficient DNA mismatch repair tumors, cooperated by Japanese Society of Medical Oncology, First Edition.
Mishima S, Taniguchi H, Akagi K, Baba E, Fujiwara Y, Hirasawa A, Ikeda M, Maeda O, Muro K, Nishihara H, Nishiyama H, Takano T, Tsuchihara K, Yatabe Y, Kodera Y, Yoshino T. Mishima S, et al. Among authors: hirasawa a. Int J Clin Oncol. 2020 Feb;25(2):217-239. doi: 10.1007/s10147-019-01498-8. Epub 2019 Jul 8. Int J Clin Oncol. 2020. PMID: 31286289 Free PMC article.
Japan society of clinical oncology/Japanese society of medical oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors, cooperated by the Japanese society of pediatric hematology/oncology.
Naito Y, Mishima S, Akagi K, Igarashi A, Ikeda M, Okano S, Kato S, Takano T, Tsuchihara K, Terashima K, Nishihara H, Nishiyama H, Hiyama E, Hirasawa A, Hosoi H, Maeda O, Yatabe Y, Okamoto W, Ono S, Kajiyama H, Nagashima F, Hatanaka Y, Miyachi M, Kodera Y, Yoshino T, Taniguchi H. Naito Y, et al. Among authors: hirasawa a. Int J Clin Oncol. 2020 Mar;25(3):403-417. doi: 10.1007/s10147-019-01610-y. Epub 2020 Jan 24. Int J Clin Oncol. 2020. PMID: 31974683 Free PMC article.
Germline Whole-Gene Deletion of FH Diagnosed from Tumor Profiling.
Ueki A, Sugano K, Misu K, Aimono E, Nakamura K, Tanishima S, Tanaka N, Mikami S, Hirasawa A, Ando M, Yoshida T, Oya M, Nishihara H, Kosaki K. Ueki A, et al. Among authors: hirasawa a. Int J Mol Sci. 2021 Jul 26;22(15):7962. doi: 10.3390/ijms22157962. Int J Mol Sci. 2021. PMID: 34360727 Free PMC article.
Hereditary gynecologic tumors and precision cancer medicine.
Ogawa C, Hirasawa A, Ida N, Nakamura K, Masuyama H. Ogawa C, et al. Among authors: hirasawa a. J Obstet Gynaecol Res. 2022 May;48(5):1076-1090. doi: 10.1111/jog.15197. Epub 2022 Feb 28. J Obstet Gynaecol Res. 2022. PMID: 35229413 Review.
Current status and issues related to secondary findings in the first public insurance covered tumor genomic profiling in Japan: multi-site questionnaire survey.
Minamoto A, Yamada T, Shimada S, Kinoshita I, Aoki Y, Oda K, Ueki A, Higashigawa S, Morikawa M, Sato Y, Hirasawa A, Ogawa M, Kondo T, Yoshioka M, Kanai M, Muto M, Kosugi S. Minamoto A, et al. Among authors: hirasawa a. J Hum Genet. 2022 Oct;67(10):557-563. doi: 10.1038/s10038-022-01028-x. Epub 2022 Mar 23. J Hum Genet. 2022. PMID: 35322199
Human resources for administrative work to carry out a comprehensive genomic profiling test in Japan.
Kage H, Oda K, Muto M, Tsuchihara K, Okita N, Okuma Y, Kikuchi J, Shirota H, Hayashi H, Kokuryo T, Sakai D, Hirasawa A, Kubo M, Kenmotsu H, Akiyama N, Shinozaki-Ushiku A, Tanabe M, Ushiku T, Miyagawa K, Seto Y. Kage H, et al. Among authors: hirasawa a. Cancer Sci. 2023 Jul;114(7):3041-3049. doi: 10.1111/cas.15833. Epub 2023 May 10. Cancer Sci. 2023. PMID: 37165760 Free PMC article.
Patient survey on cancer genomic medicine in Japan under the national health insurance system.
Kage H, Akiyama N, Chang H, Shinozaki-Ushiku A, Ka M, Kawata J, Muto M, Okuma Y, Okita N, Tsuchihara K, Kikuchi J, Shirota H, Hayashi H, Kokuryo T, Yachida S, Hirasawa A, Kubo M, Kenmotsu H, Tanabe M, Ushiku T, Muto K, Seto Y, Oda K. Kage H, et al. Among authors: hirasawa a. Cancer Sci. 2024 Mar;115(3):954-962. doi: 10.1111/cas.16065. Epub 2024 Jan 26. Cancer Sci. 2024. PMID: 38273803 Free PMC article.
384 results